← Open Payments lookup

JOHN VALLES: Open Payments

NPI 1972545994 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,958 in 85 payments from 9 companies in 2025. Trend: 2023 $1,536 · 2024 $1,735 · 2025 $1,958

Food & beverage: $1,958
CompanyPaymentsAmount
Alkermes, Inc.17$448
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$352
Janssen Pharmaceuticals, Inc8$279
Otsuka America Pharmaceutical, Inc.11$222
E.R. Squibb & Sons, L.L.C.10$218
Neurocrine BioSciences, Inc.10$177
Teva Pharmaceuticals USA, Inc.11$166
Vanda Pharmaceuticals Inc.3$69
ABBVIE INC.1$26

Products named: CAPLYTA, ARISTADA, INVEGA SUSTENNA, COBENFY, REXULTI, INGREZZA, LYBALVI, AUSTEDO XR.

Industry payments across NV — which companies pay providers there.